Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Marex Group Limited Ordinary Shares (MRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Marex Group Limited Ordinary Shares — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $14.19 (market cap $6.04B), while Marex Group Limited Ordinary Shares trades at $71.46 (market cap $5.12B). The key difference: Iovance Biotherapeutics Inc. Common Stock is the larger of the two by market cap, and Marex Group Limited Ordinary Shares pays a 0.9% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Marex Group Limited Ordinary Shares for 0 Days on average.
| IOVA | MRX | |
|---|---|---|
Market Cap | $6.04B | $5.12B |
Volume | 14,805,993 | 647,370 |
Sector | Health | Financials |
52-Week High | $14.82 | $78.27 |
52-Week Low | $1.81 | $29.92 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.97B | $8.20B |
Dividend Yield | — | 0.9% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Marex Group Limited Ordinary Shares
Marex Group provides financial services across commodities, financial markets, and corporate clients. Its services include clearing, agency and execution, market making, hedging, and securities services.
Read more on MRX →
